According to the US Centers for Disease Control and Prevention (CDC)’s latest weekly US Influenza Surveillance Report, influenza activity is continuing to increase in the US.
Chinese officials have announced that the Mount Everest base camp in Tibet is to be closed to tourists ‘until further notice’, so that the rubbish that has piled up there can be cleaned up.
Southeast Asia-based private hospital Bumrungrad International is partnering with genomic data management and analytics company BC Platforms, enabling the hospital to offer personalised healthcare.
Research conducted by medical travel insurance comparison website Medical Travel Compared has revealed that large numbers of British travellers are foregoing travel insurance due to steep pricing and perceived insufficient cover options.
AXA Partners has announced the launch of AXA Affiliates, a new insurance-as-a-service (IaaS) platform that will give its digital partners the opportunity to provide travel insurance for their customers.
The Health Insurance Group, a provider of health and wellbeing advice and solutions, has warned that businesses with employees that travel to the European Union for work should ensure all passports are renewed in time for the potential outcome of a ‘no-deal’ Brexit situation after 29 March.
Recent disease outbreak news from the World Health Organization highlights that in Brazil it is currently the seasonal period for yellow fever and that further transmission of the disease is expected in the coming months based on seasonal patterns.
Canada’s federal Government has issued an advisory to Canadians planning on taking a spring break trip; one of the many tips strongly suggests that they should purchase travel insurance.
In a move which aims to quell perceptions of Thailand as a dangerous tourist destination, the Tourism Council of Thailand (TCT) is teaming up with state agencies such as the Department of Land Transport, Marine Department and Tourism Authority of Thailand (TAT) to improve tourist safety standards across the country.
Following changes in the UK that allow specialist doctors to prescribe cannabis-based products for medicinal use (CBPM), Australian medicinal cannabis company Althea Group Holdings Limited (Althea) has launched in the UK as Althea MMJ UK (Althea UK).